Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer:

Baomin Chen,Donghua Zheng,Weiguang Yu,Cuiping Huang,Junxing Ye,Guowei Han,Jintao Zhuang

Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer:

2020

Baomin Chen
Donghua Zheng
Weiguang Yu
Cuiping Huang
Junxing Ye
Guowei Han
Jintao Zhuang

ObjectiveTo assess the efficacy and safety of cetuximab (CE) versus bevacizumab (BE) maintenance treatment after prior 8-cycle modified 5-fluorouracil, folinate, oxaliplatin, and irinotecan (FOLFOX...

Keywords:

Colorectal cancer
Internal medicine
Irinotecan
Oncology
FOLFOXIRI
KRAS
Bevacizumab
Oxaliplatin
FOLFOX
Cetuximab
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations